This means your body isn't processing fats (lipids) correctly. It's like a problem with the engine that breaks down fats, leading to issues with how your body uses them.
Every report comes from a Lived member, sent anonymously.
Have you tried Lipitor (Atorvastatin) for Lipid Metabolism Disorders?
Lipid metabolism disorders are conditions in which the body cannot handle lipids normally. Lipids are fats and fat-like substances, including cholesterol and triglycerides, that the body uses for energy, cell structure and hormones. When the way they are broken down, carried or cleared goes wrong, they build up where they cause harm. The label covers two very different kinds of problem. The common kind is a blood lipid disorder, sometimes called dyslipidemia: too much LDL (low-density lipoprotein) cholesterol, the kind that builds up in artery walls, or too many triglycerides in the blood. It usually causes no symptoms, but over years it drives the buildup of fatty plaque in the arteries, which raises the risk of heart attack and stroke. The rare kind is an inherited lipid storage disease, such as Gaucher disease, Tay-Sachs disease, Niemann-Pick disease or Fabry disease. In these, a missing or faulty enzyme lets fatty material collect inside cells, where it can damage the brain, nerves, liver, spleen, heart and bone marrow. Many storage diseases begin in infancy or childhood, and some are severe. Because the two groups differ so much in cause, outlook and treatment, the most useful first question is which specific disorder a person has.
For high cholesterol and high triglycerides, genes and everyday factors usually combine. Eating a lot of saturated fat, getting little physical activity, carrying excess weight, smoking and drinking heavily all push lipid levels in the wrong direction. Some health conditions raise them too, including diabetes, an underactive thyroid (hypothyroidism), and kidney or liver disease. Certain medicines, such as steroids, can also raise them. Levels also tend to rise with age. Familial hypercholesterolemia (FH) is an important inherited exception. It affects roughly 1 in 200 to 250 people. A gene change keeps the liver from clearing LDL cholesterol from the blood, so levels are very high from early life and coronary artery disease can develop at a young age. Lipid storage diseases are caused entirely by inherited gene changes. Most are recessive: a child is affected only when both parents pass on a changed copy of the gene, and when both parents are carriers, each pregnancy has a 25% chance of an affected child. Fabry disease is different because the gene is on the X chromosome, so it mainly affects boys and men, although women and girls can have symptoms too. Some of these diseases are more common in particular communities, such as Tay-Sachs disease and Gaucher disease among people of Ashkenazi Jewish ancestry.
Blood lipid disorders are found with a lipid panel, a blood test that reports total cholesterol, LDL ("bad") cholesterol, HDL ("good") cholesterol, which carries cholesterol back to the liver to be removed, and triglycerides in milligrams per deciliter (mg/dL). For triglycerides, under 150 mg/dL is normal, 150 to 199 is borderline high, 200 to 499 is high and 500 or above is very high, the range in which the risk of acute pancreatitis rises. LDL is read differently: there is no single cutoff for everyone, and a clinician weighs the number alongside age, blood pressure, diabetes, smoking and family history, because the same LDL level matters more for someone whose overall heart risk is already high. A very high LDL, especially with early heart disease in close relatives, raises the possibility of FH, which genetic testing can confirm. In the US, cholesterol screening usually starts at ages 9 to 11 and is repeated about every 5 years in younger adults, then more often from middle age. Children can be checked as early as age 2 when there is a family history of high cholesterol, heart attack or stroke. Lipid storage diseases are diagnosed differently. Some are picked up by newborn screening, which varies by state. Otherwise, a specialist combines a physical examination with blood or urine tests that measure enzyme activity or stored material, genetic testing and sometimes a tissue biopsy. Because early symptoms overlap between forms, reaching a diagnosis can take time. Carrier and prenatal testing are available to families who know a disorder runs in them, and a genetic counselor can explain what the results mean.
For blood lipid disorders, the goal is not a better number for its own sake but a lower chance of heart attack and stroke over the years ahead. Eating less saturated fat and more soluble fiber, staying physically active, managing weight, not smoking and limiting alcohol help many people, and they still matter when medicine is needed. Cutting back on sugar, refined foods and alcohol is especially relevant when triglycerides are high. Statins, such as atorvastatin (Lipitor), are the most widely used medicine. They reduce the amount of cholesterol the liver makes and have been shown to lower the risk of heart attack and stroke in people with high LDL. Most people take them without side effects. They can slightly raise the chance of developing diabetes, mainly in people already close to it, and muscle damage is rare. When a statin is not enough or not tolerated, other medicines can be added or substituted. Ezetimibe (Zetia) blocks the absorption of cholesterol from the gut. Bempedoic acid is a pill that, like a statin, reduces the cholesterol the liver makes. Bile acid sequestrants keep bile acids, which the liver makes from cholesterol, from being reabsorbed in the gut, which lowers LDL. PCSK9 inhibitors, such as evolocumab (Repatha) and alirocumab (Praluent), are injections under the skin that block or reduce a liver protein called PCSK9 so the liver can remove more LDL from the blood. They are often used for FH or very high heart risk, and people with FH often need a combination of medicines. Very high triglycerides call for treatment for a more immediate reason. At 500 mg/dL or above, the main concern is acute pancreatitis, a sudden and painful inflammation of the pancreas, so bringing the level down matters in the near term and not only for long-term heart risk. Alongside cutting back on sugar and alcohol, treatment includes getting underlying causes such as poorly controlled diabetes or an underactive thyroid under control, and often a medicine aimed at triglycerides. Fibrates, such as fenofibrate, lower triglycerides in the blood. Icosapent ethyl (Vascepa) is a prescription omega-3 medicine; it is made differently from omega-3 supplements, which are not approved to treat high triglycerides. Statins also lower triglycerides to some degree. For lipid storage diseases, treatment depends entirely on the specific disease. A few have treatments aimed at the cause. Enzyme replacement therapy, given by intravenous infusion, supplies the missing enzyme in Gaucher disease and Fabry disease, and it is approved for the non-brain symptoms of one form of Niemann-Pick disease. Substrate reduction therapy, taken by mouth and used mainly for Gaucher disease type 1, lowers the production of the material that builds up. These treatments can work well on the liver, spleen, blood and bones, but they do not treat the brain damage of the severe childhood forms of Gaucher disease. For many others, including Tay-Sachs disease, only supportive care is available: nutrition and feeding support, seizure medicines and help keeping the airway clear. Stem cell transplantation or gene therapy is used for a small number of specific diseases.
High cholesterol and high triglycerides are usually long-term tendencies rather than problems fixed once. Most people feel no different when their numbers improve; the benefit is fewer heart and blood vessel problems over time. Repeat lipid panels after a change in treatment, and then at regular intervals, show whether the plan is working and whether it needs adjusting. Because FH is inherited, a diagnosis in one person is a reason for parents, siblings and children to have their cholesterol checked, so that others can be treated before heart disease develops. The outlook for lipid storage diseases varies enormously from one disease to another. Gaucher disease type 1 can appear at any age, does not affect the brain and usually responds very well to enzyme replacement, which means ongoing infusions and monitoring. Some forms, such as Niemann-Pick disease type C, may first appear in the teen or adult years and progress slowly. Others, including the classic infantile form of Tay-Sachs disease and the infantile forms of Gaucher and Niemann-Pick disease, progress quickly in infancy and are usually fatal in early childhood. For families facing a severe form, care often shifts toward comfort, feeding, breathing support and planning, and a genetic counselor can help them understand the chances in future pregnancies.
Ask for a cholesterol check if you have never had one, or if a parent or sibling has very high cholesterol, FH, or had a heart attack or stroke at a young age. Yellowish lumps on the Achilles tendons, the tendons of the hands or the eyelids can be cholesterol deposits and are worth showing to a clinician. If a lipid-lowering medicine causes troublesome side effects, contact the prescriber to adjust the plan rather than stopping it on your own. Arrange a prompt evaluation for a baby or child who loses skills they had already gained, develops a swollen belly, or has unexplained problems with movement, swallowing, vision or hearing, especially when a lipid storage disease runs in the family. If you have very high triglycerides and develop severe or worsening pain in the upper belly, often spreading to the back, with nausea or vomiting, get medical care right away, because this can be acute pancreatitis.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Lipid Metabolism Disorders is like, what's helped you, or ask the community a question.